[gpfsug-discuss] CNFS

[McLaughlin, Sandra M]

Hi Chris,

 

I wasn't in Liverpool last week - but I am currently using CNFS on top
of GPFS. It seems to work OK, but I am not exactly pushing it, and I
have not rigorously tested the failover (I am only using it for a couple
of test scratch areas at the moment). It was very easy to setup (except
that since we do not run the DNS here at AZ, we couldn't get a round
robin DNS entry setup, so we have to explicitly point clients at one of
the servers). 

 

When I asked a couple of questions about CNFS at the GPFS users meeting
at Daresbury earlier this year, there were people who were using it, but
it seemed to me that the general consensus was that people preferred
using CTDB to get highly-available NFS and CIFS serving. I am just about
to take delivery of a new V7000 and new NSDs, so I plan to try out CTDB
with this.

 

Regards, Sandra.

 

Sandra McLaughlin

Scientific Computing Specialist

___________________________________________________

AstraZeneca

R&D | R&D Information

30F49, Mereside, Alderley Park, GB-Macclesfield, SK10 4TG

Tel +44 1625 517307

sandra.mclaughlin at astrazeneca.com
<mailto:sandra.mclaughlin at astrazeneca.com> 

 

 

 

 

From: gpfsug-discuss-bounces at gpfsug.org
[mailto:gpfsug-discuss-bounces at gpfsug.org] On Behalf Of Edsall,
Christopher J.
Sent: 03 December 2012 16:43
To: gpfsug-discuss at gpfsug.org
Subject: [gpfsug-discuss] CNFS

 

Hi All,

 

It was good to meet those of you who made it to the meeting in Liverpool
last week. 

 

Something I should have asked there but forgot is: has anyone tried CNFS
on top of GPFS?

(http://www.redbooks.ibm.com/abstracts/redp4400.html )

 

If so, what are your thoughts?

 

Cheers,

Chris Edsall

IT Systems Manager

National Oceanography Centre, Southampton

+44 (0)23 8059 6034

 

 

________________________________

This message (and any attachments) is for the recipient only. NERC is
subject to the Freedom of Information Act 2000 and the contents of this
email and any reply you make may be disclosed by NERC unless it is
exempt from release under the Act. Any material supplied to NERC may be
stored in an electronic records management system.


--------------------------------------------------------------------------
AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 2 Kingdom Street, London, W2 6BD.
Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful.
Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email.
Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking Compliance with our Code of Conduct and Policies.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://gpfsug.org/pipermail/gpfsug-discuss_gpfsug.org/attachments/20121203/99a29857/attachment-0003.htm>